Growth Stock Analytics-High EPS and Relative Strength Stock Market Trading System Growth Stock Analytics-High EPS and Relative Strength Stock Market Trading System
Growth Stock Investing and Trading for Stock Market Investors - Since 1996 | MyStockScreen.com | Home | Join Now | Member Login | Refer a Friend | Contact Us
Your Best Source For Top Stock Picks, Stock Rankings, Stock Screening, Swing Trading, Market Direction and More...
HI-EPSRS
Screener
My Watch
List
Market
Direction
Industry
Map
My
Account
Help Logout
Symbol:
Enter Symbols Separated By Spaces.
Download All Symbols To Text/CSV

Top Picks Watch List
Dist.Days: SPY:4 DOW:4 QQQ:2

GSA Live Portfolio:
FNSR PRO
2022-11-08: We have a signal to move out of CASH and into FBSOX....Read more

HI-EPSRS Database Search Results   

Search Results      Stocks 1 through 1 of 1 shown        Download Search Results Symbols To Text/CSV

Abiomed Inc (ABMD)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.6/1.0
Sales
Consistency

Sales Consistency Ranking

1.0/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

4/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

5%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
80.07
Acc Dist
1.46
Disc
163.59%
Avg Vol
322,000
Liquidity
0.79%
Below High
0.13%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
170%  183%
EPS Growth
77%
Sls Growth
30%
Proj Growth
31.5%
Anal. Rank
4.38
Shares
44.2M
Instit
92%
3-Month Trends of Key Indicators:
Looks Like a Winner?
ABMD looks better than most Top Picks Winners* in 4 out of 10 key factors.
Accum/Dist: 1.46 (median winner: 1.53)
Above 40wkMA: 34% (median winner: 35%)
Instit. Ownership: 92% (median winner: 63%)
Liquidity: 0.79% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 80.07 (winner: 75.66)
Sales Growth: 30% (median winner: 28%)
Below 52wk High: 0.13% (winner: 3.30%)
Relative Strength: 95 (winner: 96)
Avg Qrtly EPS: 176% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

  • ETFs with exposure to ABIOMED, Inc. : November 24, 2017 Fri, 24 Nov 2017 15:20:02 +0000
    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ABIOMED, Inc. Here are 5 ETFs with the largest exposure to ABMD-US. Comparing the performance and risk of ABIOMED, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
  • 7 Tech Stocks to Buy That Sport Amazon-Like Growth Fri, 10 Nov 2017 17:51:37 +0000
    There’s no doubt that we continue to be in a growth-fueled market. This hasn’t always been the case. In case you’ve forgotten, after the financial meltdown, it was dividend stocks that were the ‘new’ growth stocks. Everyone was scrambling for dividends, and not surprisingly, many stocks began to offer tantalizing dividends.
  • ABIOMED, Inc. :ABMD-US: Earnings Analysis: Q2, 2018 By the Numbers : November 8, 2017 Wed, 08 Nov 2017 19:27:52 +0000
    Categories: Yahoo FinanceGet free summary analysis ABIOMED, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of ABIOMED, Inc. – Teleflex Incorporated, Boston Scientific Corporation and AtriCure, Inc. (TFX-US, BSX-US and ATRC-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 132.82 ... Read more (Read more...)
  • Abiomed (ABMD) Looks Good: Stock Adds 7.5% in Session Wed, 01 Nov 2017 12:35:12 +0000
    Abiomed (ABMD) was a big mover last session, as the company saw its shares rise more than 7% on the day amid huge volumes.
  • Top Ranked Momentum Stocks to Buy for October 31st Tue, 31 Oct 2017 15:32:03 +0000
    Top Ranked Momentum Stocks to Buy for October 31st
  • Abiomed (ABMD) Earnings and Revenues Beat Estimates in Q2 Mon, 30 Oct 2017 11:56:11 +0000
    Abiomed's (ABMD) strong performance in Impella heart pump boosted the company's second-quarter 2018 results.
  • Company News For Oct 27, 2017 Fri, 27 Oct 2017 14:17:02 +0000
    Companies in the news are: TWTR,F,BMY,ABMD
  • Abiomed beats Street 2Q forecasts Thu, 26 Oct 2017 11:35:30 +0000
    The Danvers, Massachusetts-based company said it had profit of 54 cents per share. Earnings, adjusted for non-recurring gains, were 44 cents per share. The results exceeded Wall Street expectations. The ...
  • See what the IHS Markit Score report has to say about Abiomed Inc. Tue, 17 Oct 2017 12:07:12 +0000
    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
  • Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark Wed, 11 Oct 2017 07:00:00 +0000
    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
ABMD EPS/Sales Growth ABMD vs. Peers



*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Copyright © 1996-2024 Growth Stock Analytics, LLC. All rights reserved.  Site Map | Privacy Policy | Contact Us